GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSTO:PHOO) » Definitions » Asset Impairment Charge

PhotoCure ASA (OSTO:PHOO) Asset Impairment Charge : kr0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA Asset Impairment Charge?

PhotoCure ASA's Asset Impairment Charge for the three months ended in Mar. 2025 was kr0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.0 Mil.

PhotoCure ASA Asset Impairment Charge Historical Data

The historical data trend for PhotoCure ASA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Asset Impairment Charge Chart

PhotoCure ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PhotoCure ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PhotoCure ASA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

PhotoCure ASA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSTO:PHOO) » Definitions » Asset Impairment Charge
Comparable Companies
OSL:VISTN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124 NBIX BOM:532321
Traded in Other Exchanges
PHCUF:USA PHO:Norway 0IMT:UK PHS:Germany PHS:Germany
Address
Hoffsveien 4, Oslo, NOR, 0275
Website
https://www.photocure.com
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

PhotoCure ASA Headlines

No Headlines